Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Operating Leases: 2022-2024

Historic Operating Leases for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Dec 2024 value amounting to $202,000.

  • NewAmsterdam Pharma Co N.V's Operating Leases fell 68.05% to $85,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $85,000, marking a year-over-year decrease of 68.05%. This contributed to the annual value of $202,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, NewAmsterdam Pharma Co N.V's Operating Leases is $202,000, which was up 236.67% from $60,000 recorded in FY2022.
  • In the past 5 years, NewAmsterdam Pharma Co N.V's Operating Leases ranged from a high of $202,000 in FY2024 and a low of $60,000 during FY2022.
  • In the last 2 years, NewAmsterdam Pharma Co N.V's Operating Leases had a median value of $131,000 in 2022 and averaged $131,000.